溶剂化
钯 (II) 与潜在的环
钯化单苄基三胺
配体 [Pd(CH3CN)(BnPhdptn)](
BF4)2 (1) (BnPhdptn = N-(3-
氨基丙基)-N'-苄基-N-苯基-
1,3-丙二胺), [Pd(CH3CN)(Bndptn)]( )2(2) (Bndptn = N-(3-
氨基丙基)-N'-苄基-
1,3-丙二胺), [Pd( CH3CN)(4-XC6H4CH2dptn)]( )2 (4-XC6H4CH2dptn = N-(3-
氨基丙基)-N'-(4-取代苄基)-
1,3-丙二胺;X = Me (3), MeO ( 4)、Cl (5) 和
NO2 (6)) 和 [Pd(CH3CN)(4-XC6H4CH2Medptn)]( )2 (4-XC6H4CH2Medptn = N-(3-
氨基丙基)-N'-(4-已合成取代苄基)-N-甲基-
1,3-丙二胺;X = Et (8)、Me